Wesam Ismail is a registered pharmacist and PhD candidate in the College of Pharmacy, focusing on pharmacoepidemiology – the utilization and effects of drugs in large numbers of people.
News
March 12, 2021
March is Women's History Month, and we proudly honor alumna Helen Eddy, director of the Polk County Health Department -- one of Iowa’s largest health departments. It is a post that she relishes even in a pandemic.
February 22, 2021
Eddy Airiohuodion, '17 PharmD and Genesis Board member, is passionate about many things: helping the clients who frequent the Walmart pharmacy he manages, providing life-saving medications to his home country of Nigeria, and supporting his wife, Olabimpe, and daughter, I
February 15, 2021
Maurice Shaw, '13 R (community resident), has been inundated lately with job opportunities. Pharmacies and public health institutions are frantically searching for trained professionals to administer and document COVID-19 vaccinations and monitor patients for side effects. Shaw is a clinical pharmacist at the University of Illinois at Chicago
February 11, 2021
Associate Professor Reza Nejadnik has experience working in academic and industrial settings and has played critical roles on multi-national research teams in Europe and the U.S.
January 19, 2021
When Yury Kim started college in Seoul, South Korea, she enrolled in classes to become an English teacher, eventually completing a bachelor’s degree in language instruction. But when she married an American and moved to Iowa, she decided to take a very different direction and go back to school to become a pharmacist.
December 29, 2020
Third-year PharmD student Allen Erika Baugh is a scientist first, but she also has some amazing artistic skills.
December 15, 2020
Rick Gates doesn't have to read headlines to know what's the latest COVID-19 vaccine news.
December 11, 2020
UI Pharmaceuticals, provider of contract pharmaceutical product development and manufacturing services, and a division of the University of Iowa College of Pharmacy has been awarded two new drug supply contracts.